Oncolytics Biotech's Nevada Move Resets Capital Access And Dilution Trade Off [Yahoo! Finance]
Oncolytics Biotech Inc. - Common Shares (ONCY)
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.oncolyticsbiotech.com
Company Research
Source: Yahoo! Finance
Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Oncolytics Biotech (NasdaqCM:ONCY) has completed its transition of incorporation from Alberta, Canada to Nevada, United States. The company has shifted its corporate headquarters to the U.S., with the move now formally in effect. Management has highlighted goals of greater operational efficiency and improved access to U.S. capital markets following the relocation. Oncolytics Biotech focuses on developing cancer therapeutics, and this jurisdiction change comes at a time when access to capital and regulatory clarity can be important for biotech pipelines. For investors, the move places NasdaqCM:ONCY within a U.S. corporate framework that many institutions and retail shareholders already work with regularly. This new base in Nevada may influence how the company interacts with regulators, exchanges, and potential partners. Investors will likely monitor how the shift affects corporate govern
Show less
Read more
Impact Snapshot
Event Time:
ONCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCY alerts
High impacting Oncolytics Biotech Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ONCY
News
- Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal CancerGlobeNewswire
- Oncolytics Biotech (ONCY) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ONCY&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "stronMarketBeat
- Oncolytics Biotech® Completes Domicile Change to the United StatesGlobeNewswire
- The Patent Cliff is Coming, Driving Smart Money Towards Precision OncologyGlobeNewswire
- Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
ONCY
Earnings
- 3/30/26 - Miss
ONCY
Sec Filings
- 4/6/26 - Form F-10POS
- 4/6/26 - Form F-10POS
- 4/6/26 - Form F-10POS
- ONCY's page on the SEC website